Genomic alterations in histopathologically normal breast tissue from BRCA1 mutation carriers may be caused by BRCA1 haploinsufficiency.
Multiple biopsies of normal breast tissue from 10 BRCA1 mutation carriers have been analyzed using array-based comparative genomic hybridization. Normal breast tissue from five age-matched control subjects without a family history of breast cancer was included for reference purposes. We repeatedly found multiple low copy number aberrations at a significantly higher frequency in histopathologically normal tissue from BRCA1 mutation carriers than in normal control tissue. Some of these aberrations were similar across samples from different patients and linked to biological functions such as transcriptional regulation and DNA binding. We also observed a high degree of genomic heterogeneity between samples from the same patient, suggestive of tissue heterogeneity and etiological clonality in the breast epithelium. We show that neither loss of heterozygosity nor promoter methylation of the wild-type BRCA1 allele is the predominant mechanistic origin of the observed genomic instability. Instead, we propose that haploinsufficiency of BRCA1 might be the underlying cause responsible for initiation of breast cancer in these predisposed women, making cells vulnerable to mitotic recombination. We also propose that loss of ERalpha expression is preceded by genetic instability in the initiation of BRCA1-dependent tumorigenesis, indicating that the breast epithelium of BRCA1 mutation carriers may initially be estrogen-responsive. Our results imply that genomic instability instigated by BRCA1 haploinsufficiency may be required for breast cancer initiation in BRCA1 mutation carriers. Finding molecular markers of tumor initiation and progression, for the potential use in early disease detection, may be of great clinical importance for the improved management of at-risk women.
Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden.
Karin
K
Rennstam
Anita
A
Ringberg
Heather E
HE
Cunliffe
Håkan
H
Olsson
Göran
G
Landberg
Ingrid
I
Hedenfalk
D000328:Adult; D019313:BRCA1 Protein / Q000235:genetics*; D001940:Breast / Q000737:chemistry*; D001943:Breast Neoplasms / Q000209:etiology; D016022:Case-Control Studies; D004848:Epithelium; D047628:Estrogen Receptor alpha; D005260:Female; D018628:Gene Dosage; D020022:Genetic Predisposition to Disease; D042822:Genomic Instability; D006239:Haplotypes; D006579:Heterozygote; D006801:Humans; D008875:Middle Aged; D009154:Mutation
D019313:BRCA1 Protein; D047628:Estrogen Receptor alpha